Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Am J Obstet Gynecol. 2015 Mar 2;213(2):208.e1–208.e4. doi: 10.1016/j.ajog.2015.02.028

Table 2.

Summary of Clinical Outcomes

Outcome New OVT (n=41) No New OVT (n=118) p
Treated with anticoagulation*, number (%) 5 (12.2) 2 (1.7) 0.012
Concomitant VTE, number (%) 3 (7.3) 4 (3.4) 0.38
Progression of OVT into IVC or left renal vein, number (%) 2 (4.9) NA NA
Cumulative incidence of VTE at 1 year, % 17.1 15.3 0.78
Overall survival at 1 year (%) 95.1 93.2 0.84§

Abbreviations: OVT, ovarian vein thrombosis; VTE, venous thromboembolic event

*

New starts who were not already anticoagulated for VTE before the index CT

Fisher's exact test

Gray's test

§

Log-rank test